Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902219-12-000449
Filing Date
2012-02-14
Accepted
2012-02-14 12:01:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 DISCLOSURE DOCUMENT sec_filing.htm SC 13G 17745
  Complete submission text file 0000902219-12-000449.txt   19666
Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487 516-961-1911
TherapeuticsMD, Inc. (Subject) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-32384 | Film No.: 12605176
SIC: 2834 Pharmaceutical Preparations

Mailing Address 280 CONGRESS STREET BOSTON MA 02210
Business Address 280 CONGRESS STREET BOSTON MA 02210 6179515000
WELLINGTON MANAGEMENT CO LLP (Filed by) CIK: 0000902219 (see all company filings)

EIN.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000